ストックスクリーナーアプリを入手
13.67
2.22%
-0.31
アフターアワーズ：
13.94
0.27
+1.98%
前日終値:
$13.98
開ける：
$14.64
24時間の取引高:
9.64M
Relative Volume:
1.44
時価総額：
$4.25B
収益：
-
当期純損益:
$-277.02M
株価収益率:
-14.65
EPS:
-0.9328
ネットキャッシュフロー:
$-91.36M
1週間 パフォーマンス:
-2.43%
1か月 パフォーマンス:
+33.11%
6か月 パフォーマンス:
+279.72%
1年 パフォーマンス:
+876.43%
1日の値動き範囲:
$13.60
$14.77
1週間の範囲:
$13.32
$14.77
52週間の値動き範囲:
$1.21
$24.28
Erasca Inc Stock (ERAS) Company Profile
Compare ERAS vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
13.67 | 4.25B | 0 | -277.02M | -91.36M | -0.9328 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-27 | 再開されました | Mizuho | Outperform |
| 2026-01-07 | 開始されました | Piper Sandler | Overweight |
| 2025-10-16 | 開始されました | Stifel | Buy |
| 2025-09-03 | ダウングレード | BofA Securities | Buy → Underperform |
| 2025-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-26 | 開始されました | Raymond James | Outperform |
| 2024-11-18 | 開始されました | Jefferies | Buy |
| 2024-03-11 | 開始されました | CapitalOne | Overweight |
| 2024-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-10-11 | 開始されました | H.C. Wainwright | Buy |
| 2023-03-30 | 開始されました | Mizuho | Buy |
| 2023-02-24 | 開始されました | Goldman | Buy |
| 2023-02-03 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
すべてを表示
Erasca Inc (ERAS) 最新ニュース
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - PR Newswire
Lost Money on Erasca, Inc. (ERAS)? Contact Levi & Korsinsky to Join Class Action Before August 10, 2026 - ACCESS Newswire
A Conversation With Biotech Firm Erasca's Chief Medical Officer On What Patients Should Know About the Growing Momentum Behind A New Class Of Oncology Drugs - SurvivorNet
Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
ERAS Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS – Company AnnouncementFT.com - Financial Times
CALIX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Calix, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ERAS Stock Slumps Nearly 40% After-Hours: Fine Print In 'Positive' Cancer Trial Reveals Treatment-Related Death - Stocktwits
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Erasca, Inc. (ERAS) Investors of August 10, 2026 Deadline - ACCESS Newswire
Lost Money on Erasca, Inc. (ERAS)? Join Class Action Before August 10, 2026Contact Levi & Korsinsky - ACCESS Newswire
Securities Lawsuit Alert: Erasca, Inc. (ERAS) InvestorsContact Levi & Korsinsky Before August 10, 2026 - ACCESS Newswire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Erasca, Inc. Investors to Secure Counsel ... - Caledonian Record
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Erasca, - GlobeNewswire
Erasca Inc (ERAS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Erasca Inc (ERAS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Erasca Inc (ERAS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Erasca Inc (ERAS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Erasca Inc (ERAS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Erasca Inc (ERAS) Institutional Confidence - TradingKey
ERAS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - mydailyrecord.com
Deadline Alert: Erasca, Inc. (ERAS) Shareholders Who Lost Money U - The National Law Review
Erasca Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
ERAS Shareholder Alert: Erasca, Inc. Securities Class Action LawsuitInvestors Should Contact SueWallSt - PR Newswire
(NASDAQ:ERAS) ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Erasca, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire
Deadline Approaching: Erasca, Inc. (ERAS) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith - lincolnjournal.com
Erasca Inc (ERAS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ERAS DEADLINE: Levi & Korsinsky Reminds Erasca, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire
Portnoy Law Firm Announces Class Action on Behalf of Erasca, Inc. Investors - GlobeNewswire
Erasca Inc (ERAS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Erasca Inc (ERAS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Contact Levi & Korsinsky by August 10, 2026 to Join Class Action Against Erasca, Inc. (ERAS) - ACCESS Newswire
Join Class Action to Recover Losses From Erasca, Inc. (ERAS)Contact Levi & Korsinsky Before August 10, 2026 - ACCESS Newswire
Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS - Barchart.com
ERAS Shareholder Alert: Investors With Losses May Seek to Lead t - GuruFocus
Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - Barchart.com
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall ... - Caledonian Record
ERAS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Erasca, Inc. Securities LawsuitContact The Gross Law Firm - PR Newswire
INVESTOR ALERT: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitERAS - TMX Newsfile
ERAS Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Erasca, Inc. - Morningstar
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ERAS ALERT: Securities Fraud Class Action Launched Against Erasca, Inc.August 10, 2026 Deadline - ACCESS Newswire
Erasca (NASDAQ: ERAS) Foundation stock sales and prior donation reported - Stock Titan
ERAS Shareholder Alert: Erasca, Inc. Securities Class - GlobeNewswire
Erasca, Inc. (ERAS) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 10, 2026 Deadline - ACCESS Newswire
INVESTOR NOTICE: Erasca, Inc. (ERAS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitRGRD Law - marketscreener.com
INVESTOR NOTICE: Erasca, Inc. (ERAS) Investors with - GlobeNewswire
ERAS Stock Slumps Against RVMD Rally — Analyst Stays Bullish - Stocktwits
Frazier Life Sciences Management, L.P.'s Erasca Inc(ERAS) Holding History - GuruFocus
Erasca Inc (ERAS) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.44%
大文字化:
|
ボリューム (24 時間):